Cargando…

The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer

The reproducibility of assessing potential biomarkers is crucial for their implementation. ONEST (Observers Needed to Evaluate Subjective Tests) has been recently introduced as a new additive evaluation method for the assessment of reliability, by demonstrating how the number of observers impact on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cserni, Bálint, Bori, Rita, Csörgő, Erika, Oláh-Németh, Orsolya, Pancsa, Tamás, Sejben, Anita, Sejben, István, Vörös, András, Zombori, Tamás, Nyári, Tibor, Cserni, Gábor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724065/ https://www.ncbi.nlm.nih.gov/pubmed/34415429 http://dx.doi.org/10.1007/s00428-021-03172-9

Ejemplares similares

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
por: Cserni, Bálint, et al.
Publicado: (2023)

Comparison of Nottingham Prognostic Index, PREDICT and PrognosTILs in Triple Negative Breast Cancer –a Retrospective Cohort Study
por: Sejben, Anita, et al.
Publicado: (2020)

TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin
por: Almási, Szintia, et al.
Publicado: (2023)

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy
por: Sejben, Anita, et al.
Publicado: (2020)

Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas
por: Zombori, Tamás, et al.
Publicado: (2020)

Proposal of a grading system for squamous cell carcinoma of the lung — the prognostic importance of tumour budding, single cell invasion, and nuclear diameter
por: Zombori-Tóth, Noémi, et al.
Publicado: (2023)

Good practice: The experiences with the utilization of residual cancer burden—A single institution study
por: Sejben, Anita, et al.
Publicado: (2023)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

The More Extensive the Spread through Air Spaces, the Worse the Prognosis Is: Semi-Quantitative Evaluation of Spread through Air Spaces in Pulmonary Adenocarcinomas
por: Zombori-Tóth, Noémi, et al.
Publicado: (2023)

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
por: Sejben, Anita, et al.
Publicado: (2023)

A Clinicopathological Approach to Odontogenic Cysts: the Role of Cytokeratin 17 and bcl2 Immunohistochemistry in Identifying Odontogenic Keratocysts
por: Cserni, Dorottya, et al.
Publicado: (2020)

Immunohistochemical Characterization of Reactive Epithelial Changes in Odontogenic Keratocysts
por: Cserni, Dorottya, et al.
Publicado: (2019)

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993)

The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019)

Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

Immunodetectable cyclin D (1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions
por: Shoker, B S, et al.
Publicado: (2001)

Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
por: de Sousa, Juarez Antônio, et al.
Publicado: (2006)

Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study
por: Shao, Xiying, et al.
Publicado: (2021)

Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer
por: Oh, Hannah, et al.
Publicado: (2016)

Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
por: Bhattacharya, D., et al.
Publicado: (1997)

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer
por: Ding, Yuqin, et al.
Publicado: (2020)

Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2022)

Alcohol consumption and breast cancer oestrogen and progesterone receptor status
por: Enger, S M, et al.
Publicado: (1999)

Intrathoracic myolipoma from parietal pleura with oestrogen and progesterone receptor
por: Teh, Jyh Shinn, et al.
Publicado: (2021)

Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion
por: Wan, Zhi-Bin, et al.
Publicado: (2018)

Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
por: Zhao, Xingjuan, et al.
Publicado: (2021)

Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer
por: Silva, Leonardo Roberto da, et al.
Publicado: (2019)

ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
por: Tuominen, Vilppu J, et al.
Publicado: (2010)

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
por: McCredie, M R E, et al.
Publicado: (2003)

Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
por: Baker, V. A., et al.
Publicado: (1992)

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
por: Pichon, M. F., et al.
Publicado: (1992)

The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
por: Davey, M G, et al.
Publicado: (2021)

Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.
por: Delarue, J. C., et al.
Publicado: (1981)

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
por: Reich, O, et al.
Publicado: (2000)

The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
por: Howat, J. M., et al.
Publicado: (1985)

Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
por: Alanko, A., et al.
Publicado: (1984)

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2023)

Progesterone receptors – animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
por: Anderson, Elizabeth
Publicado: (2002)

Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue
por: Oh, Hannah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_28c71spqass0a093bc72plvp56